Overview

A Study Evaluating Skin Irritation, Phototoxicity and Safety After Administration of LEO 90105 on Intact Skin of Healthy Japanese Male Subjects

Status:
Completed

Trial end date:
2010-12-01

Target enrollment:

Participant gender:

Summary

The objective of the trial is to investigate skin irritation, phototoxicity and safety of LEO 90105 and its components by patchtest (48 hours closed patch test and photo patch test) in healthy Japanese male subjects.

Phase:

Phase 1

Details

Lead Sponsor:

LEO Pharma

Collaborator:

Quintiles, Inc.